CD4 and CD8 co-receptors modulate functional avidity of CD1b-restricted T cells

Charlotte A. James,Yuexin Xu,Melissa S. Aguilar,Lichen Jing,Erik D. Layton,Martine Gilleron,Adriaan J. Minnaard,Thomas J. Scriba,Cheryl L. Day,Edus H. Warren,David M. Koelle,Chetan Seshadri
DOI: https://doi.org/10.1038/s41467-021-27764-w
IF: 16.6
2022-01-10
Nature Communications
Abstract:Abstract T cells recognize mycobacterial glycolipid (mycolipid) antigens presented by CD1b molecules, but the role of CD4 and CD8 co-receptors in mycolipid recognition is unknown. Here we show CD1b-mycolipid tetramers reveal a hierarchy in which circulating T cells expressing CD4 or CD8 co-receptor stain with a higher tetramer mean fluorescence intensity than CD4-CD8- T cells. CD4+ primary T cells transduced with mycolipid-specific T cell receptors bind CD1b-mycolipid tetramer with a higher fluorescence intensity than CD8+ primary T cells. The presence of either CD4 or CD8 also decreases the threshold for interferon-γ secretion. Co-receptor expression increases surface expression of CD3ε, suggesting a mechanism for increased tetramer binding and activation. Targeted transcriptional profiling of mycolipid-specific T cells from individuals with active tuberculosis reveals canonical markers associated with cytotoxicity among CD8+ compared to CD4+ T cells. Thus, expression of co-receptors modulates T cell receptor avidity for mycobacterial lipids, leading to in vivo functional diversity during tuberculosis disease.
multidisciplinary sciences
What problem does this paper attempt to address?